Onodera, Yu
Mitani, Seiji
Hosoda, Chihiro
Takabayashi, Yoko
Sakata, Asuka
Kawasaki, Ryohei
Mori, Ryota
Ohshima, Chiaki
Nishio, Kenji
Sugimoto, Mitsuhiko
Soejima, Kenji
Mackman, Nigel
Shima, Midori
Tatsumi, Kohei http://orcid.org/0000-0002-4732-1093
Article History
Received: 12 July 2023
Revised: 13 September 2023
Accepted: 14 September 2023
First Online: 27 September 2023
Declarations
:
: AS, RK, KT and MS: members of Medicinal Biology of Thrombosis and Hemostasis established by Nara Medical University and Chugai Pharmaceutical Co., Ltd. RK: an employee of Chugai Pharmaceutical Co., Ltd. a stock owner of the company. KS: an employee of KM Biologics Co., Ltd. MS: patents for inventions relating to products of Chugai Pharmaceutical Co., Ltd.; representative of Medicinal Biology of Thrombosis and Hemostasis collaborative research laboratory; research support from Chugai Pharmaceutical Co., Ltd., Takeda Pharmaceutical Co., Ltd. and CSL Behring.; honoraria or consultation fees from Chugai Pharmaceutical Co., Ltd.; speaker’s bureau from Chugai Pharmaceutical Co., Ltd., CSL Behring, Sanofi, Bayer, Novo Nordisk Pharma, Takeda Pharmaceutical Co., Ltd., Pfizer and Fujimoto Seiyaku Corp. YO, SM, CH, YT, RM, CO, KN, MS, and NM: no conflict of financial interest.